ea0004p77 | Reproduction | SFE2002
Fleming R
, Hopkinson Z
, Sattar N
C-reactive protein (CRP) is a marker of inflammatory processes which predicts vascular disease, and is raised in the circulation of women with PCOS. Metformin can be used to reduce insulin resistance in women with PCOS, leading to improved ovarian function and circulating lipid profiles. The aim of this study was to determine the effect of protracted metformin treatment on circulating CRP in women with PCOS.Methods: CRP was assessed in women with PCOS (n...